Keystone Progress Join Our Growing Network
   Please leave this field empty

What You Might Not Know About Generic Drugs

Tom Joseph, Public News Service-PA
http://www.publicnewsservice.org/index.php?/content/article/28062-1

HARRISBURG, PA - Across the nation, dozens of lawsuits against manufacturers of generic drugs have been dismissed because of a decision by the Supreme Court a year ago that makes it all but impossible to sue them for failing to provide adequate warning of a drug's dangers.

Attorney Gary Leppla, who represented the family of a young woman who had an adverse reaction to a drug and died, says it's critical to know what your health insurance plan tells your pharmacist to do.

"You have the drug manufacturers, insurance companies, really dictating medical practice. Doctors have the opportunity to be aware of the risks of various medications, and yet what is used to fill a prescription is not necessarily dictated by the doctor. It happens after it leaves the doctor's desk."

Proposed legislation in Congress would force generic drug-makers to update their warning labels when a new safety issue arises.

Leppla says you should ask your pharmacist if you're getting a generic.

"I think that consumers should be aware of this proposed legislation, which hopefully would level the playing field. We need to realize that 'big pharm' and insurance companies drive this train and the consumer has very little to say, that consumers need to gain information and network."

He says nearly 80 percent of all prescriptions in the U.S. are filled with generic drugs.

"So, it's got a tremendous impact, and the threshold question is, why should I be treated different as a consumer because I was required to have my prescription filled with a generic, as opposed to the original manufactured drug?"

Insurance companies say generic drugs save money and have the same active ingredients as the brand names. As the law stands now, generic manufacturers are not required to update their warning labels, even when they are aware of new safety issues associated with a drug's brand-name equivalent. Name-brand manufacturers however are required by the FDA to update their labels.

The Supreme Court decision referred to is Pliva v. Mensing. The legislation is S 2295 and HR 4384.

blog comments powered by Disqus

 

View posts for:

Recent Comments

Blogroll

Pennsylvania Blogs

The Pennsylvania Progressive Keystone Politics
Jan Jarrett's Ad Hoc Blog
ProgressMo Shuffle
Raging Chicken Press
CSI without Dead Bodies
Third and State
David Ginsberg's Progressive Political and Social Cause Blog
NEPArtisan
Above Average jane
Keystone Progress blog
Philly ADA
Beaver County Blue
Young Philly Politics
Three Rivers Online
The Lehigh Valley Political Blog
The Expatriate
Progressive Dispatches
Pittsburgh Women's Blogging Society Left of Centre
Lake Erie Alliance for Democracy
Gort42
Froth Slosh B'Gosh
Fact-esque
DrChuckSpeaks
DailyKos (Pennsylvania)
Comments From Left Field
A Smoke-Filled Room
2 Political Junkies

National Blogs

Afrospear
Americablog
CleanEnergy Footprints
Crooks and Liars
Daily Kos
Democratic Underground
Eschaton
Feministe
Firedoglake
Gristmill
Huffington Post
Hulaballoo
MyDD
Open Left
Pam's House Blend
Progressive States Network Blog
Shakesville
Talk Left
Talking Points Memo
Unapologetic Mexican